Pharmacokinetics

Health Care Term

Pharmacokinetics is the study of the movement of drugs through the body, including the absorption, distribution, metabolism, and elimination of drugs. It is an important field of study in the healthcare industry, as it helps researchers and healthcare professionals understand how drugs work in the body and how they can be used effectively to treat disease.

One of the key aspects of pharmacokinetics is absorption, which refers to how quickly and completely a drug is taken up by the body. This can depend on a number of factors, including the drug*s chemical properties, the method of administration (e.g. oral, intravenous), and the individual*s physiology. Distribution refers to how the drug is transported throughout the body, including how it crosses cell membranes and enters tissues.

Metabolism and elimination are also important aspects of pharmacokinetics. Metabolism refers to how the drug is broken down and transformed by the body, usually through enzymes in the liver. Elimination refers to how the drug is removed from the body, usually through the kidneys or other organs.

Understanding pharmacokinetics is important for healthcare professionals because it can help them predict how a drug will work in a specific patient and adjust the dosage accordingly. For example, if a patient has impaired liver or kidney function, they may metabolize and eliminate drugs more slowly, which could lead to toxic levels of the drug in their system if the dosage is not adjusted. In addition, pharmacokinetics is important for drug development because it can help researchers understand how a drug will behave in the body and how effective it is likely to be.

Overall, pharmacokinetics is a critical field of study in the healthcare industry, as it helps healthcare professionals understand how drugs work in the body and how they can be used safely and effectively to treat disease.


More Glossary Terms Beginning with P
  • Paediatric Exclusivity
    means, in the US, a six-month period of exclusivity to market a drug which is awarded by the FDA in return for certain paediatric clinical studies using that drug. This six-month period runs from the date of relevant patent expiry.
    Health Care Term Letter: P
  • Paid Development Method
    An actuarial method to estimate ultimate losses for a given cohort of claims such as an accident year/product line component. If the paid-to-date losses are then subtracted from the estimated ultimate losses, the result is an indication of the unpaid losses. The basic premise of the method is that cumulative paid losses for a given cohort of claims will grow in a stable, predictable pattern from y
    Insurance Term Letter: P
  • Panelboards
    Oriented strand board, particleboard, medium density fibreboard and plywood. Operating Statistics
    Manufacturing Term Letter: P
  • Partial Remission PR
    A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.
    Health Care Term Letter: P
  • Particleboard
    A panelboard produced by chemically bonding clean sawdust, small wood particles and recycled wood fibre under heat and pressure. Forestry & Wood Products Industry Operating Statistics
    Manufacturing Term Letter: P
  • Particulate Matter
    Total suspended particulate. A measure of the solid particles (wood, process dust and smoke) found in air emissions.
    Manufacturing Term Letter: P
  • Particulates
    Tiny particles of a substance.
    Manufacturing Term Letter: P
  • Passenger Load Factor
    Represents the total number of seats sold as a percentage of total seat capacity on all sectors flown. Airline Industry
    Transportation Term Letter: P
  • Passenger Mile Yield
    The amount of passenger revenue earned per revenue passenger mile during a reporting period Airline Industry
    Transportation Term Letter: P
  • Passenger revenue yield per Mile Average Yield per RPM
    Represents the average scheduled passenger fare revenue for each revenue passenger mile (RPM), or each mile a scheduled revenue passenger is flown. Airline Industry
    Transportation Term Letter: P
  • Passive Immunotherapy
    Immunologically active material transferred into the patient as a passive recipient. Monoclonal antibodies are considered Passive Immunotherapy since antibodies are generated outside the body and given to the patient
    Health Care Term Letter: P
  • Patent Term Extension
    means an extension of up to five years in the term of a US patent relating to a drug which compensates for delays in marketing resulting from the need to obtain FDA approval.
    Health Care Term Letter: P